Mitochondrial dysfunction in diabetic cardiomyopathy

Author(s): Duncan JG

Abstract

Cardiovascular disease is common in patients with diabetes and is a significant contributor to the high mortality rates associated with diabetes. Heart failure is common in diabetic patients, even in the absence of coronary artery disease or hypertension, an entity known as diabetic cardiomyopathy. Evidence indicates that myocardial metabolism is altered in diabetes, which likely contributes to contractile dysfunction and ventricular failure. The mitochondria are the center of metabolism, and recent data suggests that mitochondrial dysfunction may play a critical role in the pathogenesis of diabetic cardiomyopathy. This review summarizes many of the potential mechanisms that lead to mitochondrial dysfunction in the diabetic heart. This article is part of a Special Issue entitled: Mitochondria and Cardioprotection.

Similar Articles

Global and societal implications of the diabetes epidemic

Author(s): Zimmet P, Alberti KG, Shaw J

Diabetic cardiomyopathy

Author(s): Murarka S, Movahed MR

Diabetic cardiomyopathy--a distinct disease? Best Pract Res Clin Endocrinol Metab 23: 347-360

Author(s): Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, et al.

Oxidative stress and diabetic complications

Author(s): Giacco F, Brownlee M

Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2

Author(s): Hubbs AF, Benkovic SA, Miller DB, O'Callaghan JP, Battelli L, et al.

The transcription factor NRF2 protects against pulmonary fibrosis

Author(s): Cho HY, Reddy SP, Yamamoto M, Kleeberger SR